Brief: EMA Says Assessing Data On COVID-19 Vaccines Effectiveness, Treatments Against Omicron Subvariant BA.2

Pantera Minerals

17/02/2022 13:09

Feb 17 (Reuters) - European Medicines Agency:
    * EMA: WE ARE ASSESSING DATA ON EFFECTIVENESS OF COVID19
VACCINES
AND TREATMENTS AGAINST HIGHLY TRANSMISSIBLE OMICRON SUBVARIANT
BA.2
    * EMA - COVID-19 VACCINES APPEAR TO PROTECT AGAINST OMICRON
SUBVARIANT BA.2, AS THEY DO AGAINST OMICRON

Source text for Eikon:  ID: 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;))